National HealthCare Corporation is an American healthcare services provider. The company was founded in 1971 and is based in Murfreesboro, Tennessee. The services of the company include long-term diverse nursing and rehabilitative care to healthcare centers, facilities and hospitals in 11 states primarily in the southeastern United States. As of December, 2011, the number of the health care centers that are operated by the company reached 75 with a total of 9,456 licensed beds. As of December 2013, the company owns and operates 69 nursing facilities, 15 assisted living centers, 5 living centers with 38 homecare programs.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NHC | NATIONAL HEALTHCARE CORP | 2026-03-03 13:26:45 | 169.89 | -1.26 | -0.74 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NHC | 0001047335 | NATIONAL HEALTHCARE CORP | US6359061008 | 254900PTS11LS1JS2752 | 522057472 | NYSE | 8051 | Services-Skilled Nursing Care Facilities | 1231 | DE | 100 E. VINE ST | MURFREESBORO | TN | 37130 | UNITED STATES | US | 6158902020 | 100 E. VINE ST, MURFREESBORO, TN, 37130 | 100 E. VINE ST, MURFREESBORO, TN, 37130 | — | — | 1971 | — | — | https://www.nhccare.com | 766,100,000 | 15,515,110 | 15,515,253 | National HealthCare Corporation is an American healthcare services provider. The company was founded in 1971 and is based in Murfreesboro, Tennessee. The services of the company include long-term diverse nursing and rehabilitative care to healthcare centers, facilities and hospitals in 11 states primarily in the southeastern United States. As of December, 2011, the number of the health care centers that are operated by the company reached 75 with a total of 9,456 licensed beds. As of December 2013, the company owns and operates 69 nursing facilities, 15 assisted living centers, 5 living centers with 38 homecare programs. | 2026-02-26 17:16:02 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 900,600,000 | 134,500,000 | 17.5565 | 15,541,309 | 96,048 | 0.6219 |
| 2024 | 766,100,000 | 220,100,000 | 40.3114 | 15,445,261 | 95,272 | 0.6207 |
| 2023 | 546,000,000 | -173,700,000 | -24.1351 | 15,349,989 | -5,400 | -0.0352 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| B. Anderson Flatt | Chief Information Officer, SVP | 2024 | 260,272 | 0 | 119,034 | 464,000 | 1,817 | 1,041,104 |
| Josh A. Mccreary | Secretary, General Counsel, SVP | 2024 | 296,181 | 0 | 129,034 | 504,000 | 4,211 | 1,128,162 |
| Stephen F. Flatt | Chief Executive Officer | 2024 | 559,819 | 0 | 272,051 | 1,060,000 | 19,284 | 2,154,574 |
| Brian F. Kidd | Chief Financial Officer, SVP | 2024 | 281,351 | 0 | 132,384 | 518,000 | 3,846 | 1,130,613 |
| R. Michael Ussery | Chief Operating Officer, President | 2024 | 514,913 | 0 | 250,485 | 976,000 | 33,513 | 1,993,989 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 15,278 |
| 2024 | 14,962 |
| 2023 | 13,123 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 1,517,781,000 | 1,307,382,000 | 1,141,544,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 27,498,000,000,000 | 26,236,000 | 21,412,000 |
| Operating Expenses | 1,389,429,000 | 1,221,622,000 | 1,084,410,000 |
| Operating Income | 128,352,000 | 85,760,000 | 57,134,000 |
| Net Income | 120,015,000 | 101,927,000 | 66,798,000 |
| Earnings Per Share Basic | 7.76 | 6.62 | 4.36 |
| Earnings Per Share Diluted | 7.67 | 6.53 | 4.34 |
| Weighted Average Shares Outstanding Basic | 15,472,185 | 15,393,782 | 15,310,142 |
| Weighted Average Shares Outstanding Diluted | 15,646,338 | 15,598,528 | 15,377,343 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 92,829,000 | 76,121,000 | 107,076,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 139,002,000 | 135,325,000 | 108,545,000 |
| Inventories | 7,795,000 | 9,039,000 | 7,386,000 |
| Non Trade Receivables | — | 512,000 | 503,000 |
| Other Assets Current | — | — | — |
| Total Assets Current | 461,820,000 | 424,408,000 | 406,235,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 673,797,000 | 684,289,000 | 493,329,000 |
| Other Assets Non Current | 390,802,000 | 415,732,000 | 411,232,000 |
| Total Assets Non Current | 1,064,599,000 | 1,100,021,000 | 904,561,000 |
| Total Assets | 1,526,419,000 | 1,524,429,000 | 1,310,796,000 |
| Accounts Payable | 22,767,000 | 25,493,000 | 19,194,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 7,500,000 | 7,500,000 | — |
| Other Liabilities Current | 25,977,000 | 21,377,000 | 22,991,000 |
| Total Liabilities Current | 253,632,000 | 234,797,000 | 214,476,000 |
| Long Term Debt | 40,000,000 | 137,000,000 | — |
| Other Liabilities Non Current | 18,031,000 | 16,911,000 | 26,379,000 |
| Total Liabilities Non Current | 198,272,000 | 306,469,000 | 185,840,000 |
| Total Liabilities | 451,904,000 | 541,266,000 | 400,316,000 |
| Common Stock | 155,000 | 154,000 | 153,000 |
| Retained Earnings | 832,984,000 | 752,193,000 | 687,599,000 |
| Accumulated Other Comprehensive Income | -779,000 | -4,716,000 | -6,604,000 |
| Total Shareholders Equity | 1,068,772,000 | 980,161,000 | 908,752,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 44,920,000 | 41,985,000 | 42,034,000 |
| Share Based Compensation Expense | 4,399,000 | 4,160,000 | 2,782,000 |
| Other Non Cash Income Expense | 3,606,000 | — | — |
| Change In Accounts Receivable | 3,677,000 | 26,441,000 | 8,559,000 |
| Change In Inventories | -1,244,000 | 599,000 | 298,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -2,726,000 | 6,299,000 | 2,236,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 185,078,000 | 107,303,000 | 111,216,000 |
| Purchases Of Marketable Securities | 65,188,000 | 35,057,000 | 29,501,000 |
| Sales Of Marketable Securities | 72,893,000 | 51,970,000 | 47,396,000 |
| Acquisition Of Property Plant And Equipment | 36,446,000 | 27,600,000 | 27,901,000 |
| Acquisition Of Business | 0 | 215,896,000 | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -33,858,000 | -236,693,000 | -17,568,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 39,224,000 | 37,333,000 | 35,863,000 |
| Issuance Of Common Stock | 14,214,000 | 14,268,000 | 313,000 |
| Repurchase Of Common Stock | 14,730,000 | 13,502,000 | 2,482,000 |
| Issuance Of Long Term Debt | 0 | 150,000,000 | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -135,955,000 | 100,344,000 | -42,545,000 |
| Change In Cash | 15,265,000 | -29,046,000 | 51,103,000 |
| Cash At End Of Period | 92,829,000 | 76,121,000 | 107,076,000 |
| Income Taxes Paid | 24,719,000 | 17,525,000 | 14,571,000 |
| Interest Paid | 7,030,000 | 3,416,000 | 290,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 7.76 | 6.62 | 4.36 |
| Price To Earnings Ratio | 17.6662 | 16.2477 | 21.1972 |
| Earnings Growth Rate | 17.2205 | 51.8349 | 198.6301 |
| Price Earnings To Growth Ratio | 1.0259 | 0.3135 | 0.1067 |
| Book Value Per Share | 69.4482 | 63.8675 | 59.4691 |
| Price To Book Ratio | 1.974 | 1.6841 | 1.5541 |
| Ebitda | 196,025,000 | 165,572,000 | 123,727,000 |
| Enterprise Value | 2,075,752,841.65 | 1,724,134,191.92 | — |
| Dividend Yield | 0.0185 | 0.0225 | 0.0253 |
| Dividend Payout Ratio | 0.3268 | 0.3663 | 0.5369 |
| Debt To Equity Ratio | 0.0444 | 0.1474 | — |
| Capital Expenditures | 34,428,000 | 232,945,000 | 28,831,000 |
| Free Cash Flow | 150,650,000 | -125,642,000 | 82,385,000 |
| Return On Equity | 0.1123 | 0.104 | 0.0735 |
| One Year Beta | 0.4782 | 1.085 | 0.4643 |
| Three Year Beta | 0.6083 | 0.5435 | 0.4858 |
| Five Year Beta | 0.5471 | 0.656 | 0.6109 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Shelly Timothy J. | Sr.VP Operations | 2026-02-23 | 14,000 | A | 14,000 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | 2026-02-23 | 14,000 | A | 14,000 |
| KIDD BRIAN F | SVP, CFO | 2026-02-23 | 14,000 | A | 14,000 |
| Flatt Stephen Fowler | Director, CEO | 2026-02-23 | 20,000 | A | 20,000 |
| Dodson Vicki L | Sr.VP Patient Srvcs | 2026-02-23 | 14,000 | A | 14,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 2025-12-31 | 1,290,000 | 9,403 | 137.1903 |
| OSAIC HOLDINGS, INC. | 2025-12-31 | 349,167 | 2,547 | 137.0895 |
| Tower Research Capital LLC (TRC) | 2025-12-31 | 42,772 | 312 | 137.0897 |
| Manatuck Hill Partners, LLC | 2025-12-31 | 8,280,236 | 60,400 | 137.09 |
| JANUS HENDERSON GROUP PLC | 2025-12-31 | 833,856 | 6,097 | 136.765 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| JAMES ADVANTAGE FUNDS | 2025-12-31 | James Small Cap Fund | JASCX | 4,427 | 606,897.43 | 0.8214 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class C | RYCMX | 17 | 2,330.53 | 0.0276 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class A | RYAKX | 17 | 2,330.53 | 0.0276 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class H | RYMKX | 17 | 2,330.53 | 0.0276 |
| RYDEX DYNAMIC FUNDS | 2025-12-31 | H-Class Shares | RYRSX | 63 | 8,636.67 | 0.0158 |